Description
Added on the 13/01/2021 19:39:16 - Copyright : Wochit
The U.S. Department of Health and Human Services has expanded COVID-19 vaccine availability. The vaccine will now be made available to include people 65 and older. The changes in availability also gives priority to those with underlying health conditions. Americans who are at higher risk for serious illness from COVID-19 infection now qualify officials said. People with conditions such as diabetes, heart disease, and respiratory illnesses are at increased risk for severe COVID-19. According to UPI, HHS and CDC will be assisting states in opening new vaccination facilities.
Various US cities, Feb 10 (EFE/EPA).- The United States has reached the 10 percent threshold with 33.7 million people having received at least one of the 44.7 million doses of anti-Covid-19 vaccine that have been administered so far, the Centers for Disease Control and Prevention (CDC) reported Wednesday.Some 10.4 million people have received both doses of the two-dose vaccination series and, with the exception of Kansas, Missouri and Alabama, elsewhere in the country the rate of vaccine administration exceeds the figure of 11,000 per 100,000 residents. (Camera: ARCHIVE).ARCHIVE FOOTAGE SHOWS COVID-19 VACCINATION CAMPAIGNS AT MASS VACCINATION SITES IN THE US.
Across the country, some non-healthcare workers are getting their COVID-19 vaccines earlier than expected. In a scattershot practice, non-priority people are getting vaccinated ahead of schedule when pharmacies have extra doses thawed that must be used. Both the Pfizer-BioNTech and Moderna vaccines need to be stored at cold temperatures and used within hours of thawing. Business Insider reports the phenomenon occurs when vaccine providers must either throw out extra doses when they expire or give them to random people. In other instances, confusion about the amount of doses per vial and rumors of excess supply have led to mishaps in vaccine allocation. The US federal government hasn't specified what should be done when there are more thawed doses than eligible recipients.
Many people are concerned about severe allergic reactions to the coronavirus vaccine. But based on findings, the chances of having a severe allergic reaction are low. In the first week and a half of the US COVID-19 vaccine effort, the CDC confirmed 29 reactions. These confirmed cases are severe allergic reactions known as anaphylaxis. The cases to 29 out of 1.9 million doses administered means this reaction is very rare. That adds up to a rate of 11.1 cases of anaphylaxis out of 1 million doses administered.
The CDC unveiled an interactive vaccine-tracking map on Thursday. The map shows how many vaccine doses each state has been allocated. It also shows how many shots each has administered so far, reports Business Insider. The US fell far short of its goal to vaccinate 20 million people by the end of 2020. At its current pace, it would take the country 9 years to vaccinate the whole population. The pace must pick up in order for the vaccine to combat the virus effectively.